Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 292

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 292
---
 Class B ordinary shares will have the right to vote
on the appointment and removal of directors. Our board of directors may, by a vote of a majority of our directors then in office, appoint
any person to be a director, either to fill a vacancy or as an additional director.

Securities Eligible for Future Sale

Immediately after this offering we will have
25,000,000 (or 28,750,000 if the underwriters’ over-allotment option is exercised in full) ordinary shares outstanding. Of these
shares, the Class A ordinary shares sold in this offering (20,000,000 Class A ordinary shares if the underwriters’ over-allotment
option is not exercised and 23,000,000 shares if the underwriters’ over-allotment option is exercised in full) will be freely
tradable without restriction or further registration under the Securities Act, except for any Class A ordinary shares purchased
by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the outstanding founder shares (5,000,000
founder shares if the underwriters’ over-allotment option is not exercised and 5,750,000 founder shares if the underwriters’
over-allotment option is exercised in full) and all of the outstanding 6,000,000 private placement warrants will be restricted securities
under Rule 144, in that they were issued in private transactions not involving a public offering.

<div align='center'>153</div>

Rule 144

Pursuant to Rule 144, a person who has beneficially
owned restricted shares or warrants for at least six months would be entitled to sell their securities provided that (i) such
person is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale
and (ii) we are subject to the Exchange Act periodic reporting requirements for at least three months before the sale
and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter
period as we were required to file reports) preceding the sale.

Persons who have beneficially owned restricted
shares or warrants for at least six months but who are our affiliates at the time of, or at any time during the three months
preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month
period only a